|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 413/06 | (2006.01) |
| A61K 31/496 | (2006.01) |
| (11) | Number of the document | 1641787 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04740230.0 |
| Date of filing the European patent application | 2004-06-22 | |
| (97) | Date of publication of the European application | 2006-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2007-05-02 |
| (46) | Date of publication of the claims translation | 2007-08-27 |
| (86) | Number | PCT/EP2004/006814 |
| Date | 2004-06-22 |
| (87) | Number | WO 2005/000840 |
| Date | 2005-01-06 |
| (30) | Number | Date | Country code |
| 0314738 | 2003-06-24 | GB |
| (72) |
LIDDLE, John GlaxoSmithKline, GB
|
| (73) |
GLAXO GROUP LIMITED,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pakeistieji diketopiperazinai ir jų, kaip oksitocino antagonistų, panaudojimas |
| SUBSTITUTED DIKETOPIPERAZINES AND THEIR USE AS OXYTOCYN ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2018-06-15 | 15 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-06-22 |